"This happens from time to time on chemo treatment alone. Some make it, most dont."
Yes, the complete response in one case but none of the other 20 with anything significant enough to mention is a worry. I think the market has read that one response as an aberation.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx
Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-122
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 4542680 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 1675759 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 4342680 | 0.041 |
87 | 10259984 | 0.040 |
32 | 5714241 | 0.039 |
16 | 2839416 | 0.038 |
10 | 1400513 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 1675759 | 9 |
0.044 | 1145733 | 8 |
0.045 | 1715026 | 12 |
0.046 | 1642231 | 7 |
0.047 | 1652765 | 8 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online